[Pharmacological management of rheumatoid arthritis: the state of the art and the future perspective].

Hideto Kameda, Tsutomu Takeuchi

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Pharmacological management of rheumatoid arthritis (RA) has been rapidly progressed in recent years, which is appeared in the "treat to target" movement and the recommendations developed by some established international/domestic rheumatology associations. The baseline evaluation of poor prognostic factors as well as disease activity with composite measures is necessary for a personalized management. Methotrexate is currently the anchor drug, and other conventional or biological antirheumatic drugs should be added to it for refractory patients. The development of various novel agents including signal transduction inhibitors should promote further advances in the management of RA and other systemic autoimmune and/or inflammatory diseases.

Original languageEnglish
Pages (from-to)1166-1171
Number of pages6
JournalUnknown Journal
Volume71
Issue number7
Publication statusPublished - 2013 Jul
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of '[Pharmacological management of rheumatoid arthritis: the state of the art and the future perspective].'. Together they form a unique fingerprint.

  • Cite this